A decade separated the linking of germ-line BRCA1 mutations to familial breast and ovarian cancer [1] and the hallmark review by Turner et al, [2] wherein they suggested that somatic disruption of the function of the same genetic pathways might be encountered in a sub-set of sporadic breast cancers. The gene discussed is BRCA1; the disease is breast cancer.